Skip to main content

Is Prevention of Ventilator- Associated Pneumonia Cost Effective?

  • Chapter
Ventilator-Associated Pneumonia

Part of the book series: Perspectives on Critical Care Infectious Diseases ((CCID,volume 4))

Abstract

The prevention of VAP appears to be a cost effective endeavor based on the healthcare costs and morbidity associated with this nosocomial infection. Infection control measures should be integrated into a systematic program for general application to all patients requiring mechanical ventilation at a particular hospital (36,37). Additionally, attention needs to be focused on the emergence of antibiotic-resistant bacterial infections in the intensive care unit setting (87,88). The prevention of antibiotic-resistant bacterial infections should result in fewer overall nosocomial infections including VAP (75). At present, VAP prevention programs should employ practices which are readily accepted by local practitioners, safe for patients, and associated with acceptable costs to the institution.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Public health focus: Surveillance, prevention, and control of nosocomial infections. MMWR 1992; 41:783–787

    Google Scholar 

  2. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17:552–557.

    Article  PubMed  CAS  Google Scholar 

  3. Boyce JM, Potter-Bynoe G, Dziobek L, Solomon SL. Nosocomial pneumonia in Medicare patients. Hospital costs and reimbursement patterns under the prospective payment system.Arch Intern Med 1991; 151:1109–1114.

    Article  CAS  Google Scholar 

  4. Ascar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis 1997; 24;S17–S18.

    Article  Google Scholar 

  5. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 1992; 257:1050–1055.

    Article  CAS  Google Scholar 

  6. Impacts of antibiotic-resistant bacteria: Thanks to Penicillin - He will come home! Washington, DC; Office of Technology Assessment, Congress; 1995. Publication OTC-H-629.

    Google Scholar 

  7. Carmeli Y, Troillet N, Karchmer AW, Somore MH. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999; 159:1127–1132.

    Article  PubMed  CAS  Google Scholar 

  8. Holemberg SD, Solomon SL, Blake PA. Health and economic impact of antimicrobial resistance. Rev Infect Dis 1987; 9:1065–1078.

    Article  Google Scholar 

  9. Phelps CE. Bug-drug resistance: Sometimes less is more. Med Care 1989; 27:194–203.

    Article  PubMed  CAS  Google Scholar 

  10. Einarsson S, Kristjansson M, Kristinsson KG, Kjartansson G, Jonsson S. Pneumonia caused by penicillin-non-susceptible and penicillin-susceptible pneumococci in adults: a case-control study. Scand J Infect Dis 1998;30:253–256.

    Article  PubMed  CAS  Google Scholar 

  11. Moellering RC. A novel antimicrobial agent joins the battle against resistant bacteria. Ann Intern Med 1999;130:155–157.

    PubMed  Google Scholar 

  12. Hancock RE. The role of fundamental research and biotechnology in finding solutions to the global problem of antibiotic resistance. Clin Infect Dis 1997;24:S148–S150.

    Article  PubMed  Google Scholar 

  13. Bax RP. Antibiotic resistance: A view from the pharmaceutical industry. Clin Infect Dis 1997;24:S151–S153.

    Article  PubMed  Google Scholar 

  14. Jones RN. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diag Microbiol Infect Dis 1996;25:153–161.

    Article  CAS  Google Scholar 

  15. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am J Epidemiol 1989; 129:1258–1267.

    PubMed  CAS  Google Scholar 

  16. Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992; 102:5535–5565.

    Article  Google Scholar 

  17. Niederman MS, Craven DE, Fein AM, Schultz DE. Pneumonia in the critically ill hospitalized patient. Chest 1990; 97:170–181.

    Article  PubMed  CAS  Google Scholar 

  18. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 1995; 108:1655–1662.

    Article  PubMed  CAS  Google Scholar 

  19. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230–1235.

    Article  PubMed  CAS  Google Scholar 

  20. Craven DE, Steger KA. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 1995; 108:1S–16S.

    Article  PubMed  CAS  Google Scholar 

  21. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM. Guideline for prevention of nosocomial pneumonia. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Infect Control Hosp Epidemiol 1994; 15:587–627.

    Article  PubMed  CAS  Google Scholar 

  22. Cook DJ, Kollef MH. Risk factors for ICU-acquired pneumonia. JAMA 1998; 279:1605–1606.

    Article  PubMed  CAS  Google Scholar 

  23. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965–1970.

    Article  PubMed  CAS  Google Scholar 

  24. Cook DJ, Walter SD, Cook RJ, Griffith LE, Guyatt GH, Leasa D, Jaeschke RZ, BrunBuison C. Incidence and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129:433–440.

    PubMed  CAS  Google Scholar 

  25. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531–539.

    Article  PubMed  CAS  Google Scholar 

  26. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281–288.

    Article  PubMed  CAS  Google Scholar 

  27. Crouch Brewer S, Wunderink RG, Jones CB, Leeper KV Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109:1019–1029.

    Article  PubMed  CAS  Google Scholar 

  28. Papazian L, Bregeon F, Thirion X, Gregoire R, Saux P, Denis JP, Perin G, Charrel J, Dumon JF, Affray JP, Gouin F. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154:91–97.

    Article  PubMed  CAS  Google Scholar 

  29. Rello J, Gallego M, Mariscal D, Sonora R, Valles J. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156: 196–200.

    Article  PubMed  CAS  Google Scholar 

  30. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676–685.

    Article  PubMed  CAS  Google Scholar 

  31. Kollef MH, Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998; 113:412–420.

    Article  PubMed  CAS  Google Scholar 

  32. Kollef MH, Sherman G, Ward S, Fraser V.T. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462–474.

    Article  PubMed  CAS  Google Scholar 

  33. Kollef MH. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340:627–634.

    Article  PubMed  CAS  Google Scholar 

  34. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone W.T. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275:234–240.

    Article  PubMed  CAS  Google Scholar 

  35. Boyce.TM, White RL, Spruill EY, Wall M. Cost-effective application of the Centers for Disease Control Guideline for Prevention of Nosocomial Pneumonia. Am J Infect Control 1985; 13:228–232.

    Article  Google Scholar 

  36. Joiner GA, Salisbury D, Bollin GE. Utilizing quality assurance as a tool for reducing the risk of nosocomial ventilator-associated pneumonia. Am J Medical Quality 1996; 11:100–103.

    Article  CAS  Google Scholar 

  37. Kelleghan SI, Salemi C, Padilla S, McCord M, Mermilliod G, Canola T, Becker L. An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control 1993; 21:322–330.

    Article  PubMed  CAS  Google Scholar 

  38. Gaynes RP, Solomon S. Improving hospital-acquired infection rates: the CDC experience. Joint Commission Journal on Quality Improvement. 1996; 22:457–467.

    PubMed  CAS  Google Scholar 

  39. Berwick DM. Continuous improvement as an idea in healthcare. N Engl J Med 1989; 320:53–56.

    Article  PubMed  CAS  Google Scholar 

  40. Booth FV. ABCs of quality assurance. Crit Care Clin 1993; 9:477–498.

    PubMed  CAS  Google Scholar 

  41. Kollef MH, Horst HM, Prang L, Brock WA. Reducing the duration of mechanical ventilation: Three examples of change in the intensive care unit. New Horizons 1998; 6:52–60.

    PubMed  CAS  Google Scholar 

  42. Ely EW, Baker AM, Dunagan DP, Burke HL, Smith AC, Kelley PT, Johnson MM, Browder RW, Bowton DL, Haponik EF. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 1996; 335:1864–1869.

    Article  PubMed  CAS  Google Scholar 

  43. Kollef MH, Shapiro SD, Silver P, St. John RE, Prentice D, Sauer S, Ahrens TS, Shannon W, Baker-Clinkscale D. A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 1997; 25:567–574.

    Article  PubMed  CAS  Google Scholar 

  44. Nava S, Ambrosino N, Clini E, Prato M, Orlando G, Vitacca M, Brigada P, Fracchia C, Rubini F. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med 1998; 128:721–728.

    PubMed  CAS  Google Scholar 

  45. Antonelli M, Conti G, Rocco M, Bufi M, Deblasi RA, Vivino G, Gasparetto A, Meduri GV. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure. N Engl J Med 1998; 339:429–435.

    Article  PubMed  CAS  Google Scholar 

  46. Nourdine K, Combes P, Carton MJ, Beuret P, Cannamela A, Ducreux JC. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999; 25:567–573.

    Article  PubMed  CAS  Google Scholar 

  47. Nahum A, Hoyt J, Schmitz L, Schmitz L, Moody J, Shapiro R, Marini JJ. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coii in dogs. Crit Care Med 1997; 25:1733–1743.

    Article  PubMed  CAS  Google Scholar 

  48. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, Kairalla RA, Deheinzelin D, Munoz C, Oliveira R, Takagaki TY, Carvalho CR. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338:347–354.

    Article  PubMed  CAS  Google Scholar 

  49. Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, Li N, Wenzel RP. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992; 327:88–93.

    Article  PubMed  CAS  Google Scholar 

  50. Pittet D, Mourouga P, Perneger TV, and the Members of the Infection Control Program. Compliance with handwashing in a teaching hospital. Ann Intern Med 1999; 130:126–130.

    PubMed  CAS  Google Scholar 

  51. Pereira U, Lee GM, Wade K.J. An evaluation of five protocols for surgical handwashing in relation to skin condition and microbial counts..1 Hosp Infect 1997; 36:49–65.

    Article  CAS  Google Scholar 

  52. Klein BS, Perloff WH, Maki DG. Reduction of nosocomial infection during pediatric intensive care by protective isolation. N Engl J Med 1989; 320:1714–1721.

    Article  PubMed  CAS  Google Scholar 

  53. Torres A, Serra-Battles J, Ros E, Piera C, Puig de la Bellacasa J, Cobos A, Lomena F, Rodriguez-Roisin R. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992; 116:540–543.

    PubMed  CAS  Google Scholar 

  54. Torres A, Gatell.1M, Aznar E, el-Ebiary M, Puig de la Bellacasa J, Gonzalez J, Ferrer M, Rodriguez-Roisin R. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995; 152:137–41.

    Article  PubMed  CAS  Google Scholar 

  55. Niederman MS, Craven DE. Devising strategies for preventing nosocomial pneumonia - should we ignore the stomach? Clin Infect Dis 1997; 24:320–323.

    Article  PubMed  CAS  Google Scholar 

  56. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of trancheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989; 95:155–161.

    Article  PubMed  CAS  Google Scholar 

  57. Rouby.JJ, Laurent P, Gosnach M, Cambau E, Lamas G, Zouaoui A, Leguillou JL, Bodin L, Khac TD, Marsault C. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill. Am J Respir Crit Care Med 1994; 150:776–783.

    Article  PubMed  CAS  Google Scholar 

  58. Holzapfel L, Chastang C, Demingeon G, Bohe J. Piralla B, Coupry A. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159:695–701.

    Article  PubMed  CAS  Google Scholar 

  59. Kollef MH. Prolonged use of ventilator circuits and ventilator-associated pneumonia. A model for identifying the optimal clinical practice. Chest 1998; 113:267–269.

    Article  PubMed  CAS  Google Scholar 

  60. Kollef MH, Prentice D, Shapiro SD, Fraser VJ, Silver P, Trovillion E, Weilitz P, von Harz B, St. John R. Mechanical ventilation with or without daily changes of in-line suction catheters. Am J Respir Crit Care Med 1997; 156:466–472.

    Article  PubMed  CAS  Google Scholar 

  61. Craven DE, Goularte TA, Make BJ. Contaminated condensate in mechanical ventilator circuits. A risk factor for nosocomial pneumonia. Am Rev Respir Dis 1984; 129:625–628.

    PubMed  CAS  Google Scholar 

  62. Valles J, Artigas A, Reilo J, Bonsoms N, Fontanals D, Blanch L, Fernandez R, Baigorri F, Mestre J. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:179–186.

    PubMed  CAS  Google Scholar 

  63. Kollef MH, Skubas NJ, Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions (CASS) in cardiac surgery patients. Chest (In Press).

    Google Scholar 

  64. Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J. Pneumonia in intubated patients: role of respiratory airway care. Am J Respir Crit Care Med 1996; 154:111–115.

    Article  PubMed  CAS  Google Scholar 

  65. Kirton OC, DeHaven B, Morgan J, Morejon O, Civetta J. A prospective randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital acquired) pneumonia and incidence of endotracheal tube occlusion. Chest 1997; 112:1055–1059.

    Article  PubMed  CAS  Google Scholar 

  66. Kollef MH, Shapiro SD, Boyd V, Silver P, Von Harz B, Trovillion E, Prentice D. A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier to heated water humidification in mechanically ventilated patients. Chest 1998; 113:759–767.

    Article  PubMed  CAS  Google Scholar 

  67. Djedaini K, Billiard M, Mier L, Le Bourdelles G, Brun P, Markowicz P, Estagnasie P, Coste F, Boussougant Y, Dreyfuss D. Changing heat and moisture exchangers every 48 hours rather than 24 hours does not affect their efficacy and the incidence of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:1562–1569.

    Article  PubMed  CAS  Google Scholar 

  68. Hall JC, Tarala RA, Tapper J, Hall JL. Prevention of respiratory complications after abdominal surgery: a randomized clinical trial. BMJ 1996; 312:148–152.

    Article  PubMed  CAS  Google Scholar 

  69. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330:377–381.

    Article  PubMed  CAS  Google Scholar 

  70. Cook DJ, Reeve BK, Guyatt GH, Heyland DK, Griffith LE, Buckingham L, Tryba M. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analysis. JAMA 1996; 275:308–314.

    Article  PubMed  CAS  Google Scholar 

  71. Cook D, Guyatt G, Marshall J, Leasa D, Fuller H, Hall R, Peters S, Rutledge F, Griffith L, McLellan A, Wood G, Kirby A. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998; 338:791–797.

    Article  PubMed  CAS  Google Scholar 

  72. Johanson WG Jr, Pierce AK, Sandford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med 1972; 77:701–706.

    PubMed  Google Scholar 

  73. Garrouste-Orgeas M, Chevret S, Arlet G, Marie O, Rouveau M, Popoff N, Schlemmer B. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med 1997; 156:1647–1655.

    Article  PubMed  CAS  Google Scholar 

  74. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338:232–238.

    Article  PubMed  CAS  Google Scholar 

  75. Kollef MH, Vlasnik J, Sharpless L, Pasque C, Murphy D, Fraser V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:1040–1048.

    Article  PubMed  CAS  Google Scholar 

  76. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233–1237.

    Article  PubMed  CAS  Google Scholar 

  77. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group of Selective Decontamination of the Digestive Tract. N Engl J Med 1992; 326:594–599.

    Article  PubMed  CAS  Google Scholar 

  78. D’Amico R, Pifferi S, Leonetti C, Toni V, Tinazzi A, Liberati A. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. BMJ 1998; 316:1275–1285.

    Article  PubMed  Google Scholar 

  79. Sirvent JM, Torres A, EI-Ebiary M, Castro P, de Baffle J, Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med 1997; 155:1729–1734.

    Article  PubMed  CAS  Google Scholar 

  80. Tenover FC, McGowan JE Jr. Reasons for the emergence of antibiotic resistance. Am J Med Sci 1996; 311:9–16.

    Article  PubMed  CAS  Google Scholar 

  81. Rumbak MJ, Cancio MR. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol. Crit Care Med 1995; 23:1200–1203.

    Article  PubMed  CAS  Google Scholar 

  82. DeRiso AJ 2nd, Ladowski JS, Dillon TA, Justice JW, Peterson AC. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996; 109:1556–1561.

    Article  PubMed  CAS  Google Scholar 

  83. Russell AD. Plasmids and bacterial resistance to biocides. J Applied Microbiology 1997; 83:155–165.

    Article  CAS  Google Scholar 

  84. Herceg A. The decline of Haemophilus influenza type b disease in Australia. Communicable Diseases Intelligence 1997; 21:173–176.

    PubMed  CAS  Google Scholar 

  85. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowoski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123:518–527.

    PubMed  CAS  Google Scholar 

  86. Nuorti JP, Butler JC, Crutcher JM, Guevara R, Welch D, Holder P, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998; 338:1861–1868.

    Article  PubMed  CAS  Google Scholar 

  87. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States. Crit Care Med 1999; 27:887–892

    Article  PubMed  CAS  Google Scholar 

  88. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European Countries. JAMA 1999; 281:67–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kollef, M.H. (2001). Is Prevention of Ventilator- Associated Pneumonia Cost Effective?. In: Wunderink, R.G., Rello, J. (eds) Ventilator-Associated Pneumonia. Perspectives on Critical Care Infectious Diseases, vol 4. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0789-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0789-5_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5240-2

  • Online ISBN: 978-1-4615-0789-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics